Esik egyveleg Önmaga win cannabinoid Surichinmoi talapzat környezetszennyezés
The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
4 Dose-dependent induction of cannabinoid tetrad effects by the SCB WIN... | Download Scientific Diagram
Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission | Scientific Reports
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells | Prostate Cancer and Prostatic Diseases
Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes | eNeuro
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research
Effects of Acute Cannabinoid Agonist WIN 55, 212-2 Administration on Repeated Downshifts in Autshaping with Rats
WIN-55212-2 mesylate Supplier | CAS 131543-23-2 | Focus Biomolecules
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research
Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin